Literature DB >> 3877495

Coronary artery bypass graft surgery: clinical comparison of cold blood potassium cardioplegia, warm cardioplegic induction, and secondary cardioplegia.

A J Roberts, D D Woodhall, D G Knauf, J A Alexander.   

Abstract

An analysis of myocardial protection was performed in 45 low-risk patients undergoing coronary bypass procedures who were divided into three equal groups with similar preoperative ejection fractions and coronary artery obstructions. Group 1 (N = 15) received cold blood cardioplegia, Group 2 received cold blood cardioplegia and secondary cardioplegia, and Group 3 received cold blood cardioplegia plus warm cardioplegic induction. The aortic cross-clamp time and the number of bypass grafts were similar among the groups. The following variables were measured serially: electrocardiographic changes, serum myocardial-specific isoenzyme of creatine kinase, cardiac output, left ventricular filling pressure, ejection fraction, and left ventricular wall motion. The three methods evaluated were all effective in protecting the myocardium during global myocardial ischemia. Patients who received secondary cardioplegia (Group 2) were more likely to exhibit spontaneous defibrillation (12/15) than those in Group 1 (5/15) or Group 3 (6/15) (p less than 0.05). However, measurements of left ventricular performance and evidence of perioperative myocardial infarction were similar among all three groups. These data suggest that a standard technique of cold potassium cardioplegia alone should be the method of choice in elective, low-risk coronary bypass operations rather than this technique in combination with either of the other two more costly and complex methods evaluated in this study.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 3877495     DOI: 10.1016/s0003-4975(10)60104-x

Source DB:  PubMed          Journal:  Ann Thorac Surg        ISSN: 0003-4975            Impact factor:   4.330


  3 in total

1.  Terminal warm blood cardioplegia improves the recovery of myocardial electrical activity. A retrospective and comparative study.

Authors:  Y Hattori; Z Yang; S Sugimura; T Iriyama; K Watanabe; K Negi; M Yamashita; I Takeda; H Sugimura; R Hoshino
Journal:  Jpn J Thorac Cardiovasc Surg       Date:  2000-01

2.  Prevention of postischemic reperfusion injury: the improvement of myocardial tissue blood flow after ischemia by terminal nicorandil-Mg cardioplegia.

Authors:  H Orita; M Fukasawa; S Hirooka; T Minowa; H Uchino; M Washio
Journal:  Surg Today       Date:  1993       Impact factor: 2.549

3.  Accelerated myocardial metabolic and functional recovery with terminal nicorandil-Mg cardioplegia in heart transplantation.

Authors:  H Orita; T Shimanuki; M Fukasawa; H Abe; S Kuraoka; S Hirooka; M Washio
Journal:  Cardiovasc Drugs Ther       Date:  1991-08       Impact factor: 3.727

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.